Do neurologists in Germany adhere to the national Parkinson's disease guideline?
Sabrina Schröder1, Daniel Kuessner2, Guy Arnold3, York Zöllner4, Eddie Jones5, Marion Schaefer11Institute of Clinical Pharmacology, Charité University Medicine, CCM, Berlin, Germany; 2Basilea Pharmaceutica, Basel, Switzerland; 3Department of Neurology, Sindel...
Saved in:
Main Authors: | Sabrina Schröder, Daniel Kuessner, Guy Arnold, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/c4824bae047e4a52a59d0c1b88daf525 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Review: management of Parkinson's disease
by: Pedrosa DJ, et al.
Published: (2013) -
Adjunctive therapy in Parkinson's disease: the role of rasagiline
by: Gaines KD, et al.
Published: (2012) -
Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
by: Skogar Ö, et al.
Published: (2012) -
Sleep disturbances in Parkinson's disease patients and management options
by: Claassen DO, et al.
Published: (2011) -
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
by: Johan Lökk
Published: (2010)